🇺🇸 FDA
Pipeline program

Redefine

NSP-CT-024

Unknown other active

Quick answer

Redefine for Obesity & Overweight is a Unknown program (other) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Obesity & Overweight
Phase
Unknown
Modality
other
Status
active

Clinical trials